These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35839870)

  • 1. Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways.
    Marmolejo-Garza A; Medeiros-Furquim T; Rao R; Eggen BJL; Boddeke E; Dolga AM
    Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119326. PubMed ID: 35839870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.
    Stefanova NA; Ershov NI; Kolosova NG
    Oxid Med Cell Longev; 2019; 2019():3984906. PubMed ID: 31396299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
    Reddy PH
    Biochim Biophys Acta; 2013 Jan; 1832(1):67-75. PubMed ID: 22995655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disentangling Mitochondria in Alzheimer's Disease.
    Johri A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.
    Reddy PH; Beal MF
    Trends Mol Med; 2008 Feb; 14(2):45-53. PubMed ID: 18218341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.
    Quntanilla RA; Tapia-Monsalves C
    Curr Neuropharmacol; 2020; 18(11):1076-1091. PubMed ID: 32448104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
    Oliver DMA; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S95-S116. PubMed ID: 30932888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease.
    Nativio R; Lan Y; Donahue G; Sidoli S; Berson A; Srinivasan AR; Shcherbakova O; Amlie-Wolf A; Nie J; Cui X; He C; Wang LS; Garcia BA; Trojanowski JQ; Bonini NM; Berger SL
    Nat Genet; 2020 Oct; 52(10):1024-1035. PubMed ID: 32989324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
    Rai SN; Singh C; Singh A; Singh MP; Singh BK
    Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal transport and mitochondrial dysfunction in Alzheimer's disease.
    Riemer J; Kins S
    Neurodegener Dis; 2013; 12(3):111-24. PubMed ID: 23037012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer's disease.
    Poirier Y; Grimm A; Schmitt K; Eckert A
    Cell Mol Life Sci; 2019 Apr; 76(7):1419-1431. PubMed ID: 30683981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.